Viking Therapeutics' promising weight loss drug could revolutionize the obesity market and propel the company's stock price to new highs.
Is Viking Therapeutics Ready For Another Surge?
Read Also
- Veteran fund manager highlights lurking stock market risk
- Mark Zuckerberg fires back at a major concern about social media
- Ford CEO says he's sick and tired of making 'boring' cars
- Ginni Thomas Impersonated By Iranian Hackers in Targeted Scheme Against Trump Campaign, U.S. Indictment Alleges
- China's Reluctance To Empower Corporations Could Undermine Economic Stimulus: Report
- Scaramucci Advocates For Harris To Save The Republican Party, Says 'Electing Harris, Defeating Trump Is About Saving The GOP'
- While Trump Launches $100K Luxury Watch, Wife Melania Trump Talks About Rising Inflation: 'The Country Is Suffering, People Not Able To Buy Necessities For Their Families'
- Mary Trump Says There Are Much, Much Worse Things About Donald Trump 'Than His Shameless Hucksterism'
- Mary Trump Says There Are Much, Much Worse Things About Donald Trump 'Than His Shameless Hucksterism'
- Rep. Anna Paulina Luna's Opponent Charged With Chilling Death Threat In 2022 Primary
Latest MarketBeat
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- MicroStrategy's Returns Are 3X Higher Than Bitcoin: Time to Buy?
- What Intuitive Machines' Big NASA Contract Means for Investors
- REITs on the Rise After Rate Cuts: Where to Invest Now
- Is Viking Therapeutics Ready For Another Surge?
- AI Boom and Rate Cuts Boost Utility Stocks: Best Growth Picks
- Top 3 Homebuilder Stocks to Watch as Rates Drop
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- KB Home Slips After Earnings: What’s Next for Homebuilders?